Corpus ID: 79033343

Venclexta (Venetoclax) First BCL-2 Inhibitor Approved for High-Risk Relapsed Chronic Lymphocytic Leukemia

@inproceedings{Raedler2016VenclextaF,
  title={Venclexta (Venetoclax) First BCL-2 Inhibitor Approved for High-Risk Relapsed Chronic Lymphocytic Leukemia},
  author={Lisa A. Raedler and Rph and Medical Writer},
  year={2016}
}

References

SHOWING 1-5 OF 5 REFERENCES